Abstract
Artificial intelligence (AI) is increasingly leveraged in mental healthcare for early detection, monitoring, and personalized intervention. However, most existing AI applications are based on categorical diagnostic systems like DSM-5 or ICD-11, which often lead to comorbidity issues, ambiguous diagnoses, and insufficient personalization. These tools typically target specific disorders (e.g., depression or anxiety), neglecting the broader, interconnected nature of psychopathological symptoms. Addressing these limitations, recent innovations in psychopathology emphasize transdiagnostic and network-based approaches, such as the Hierarchical Taxonomy of Psychopathology (HiTOP), which conceptualize mental disorders as dimensional and inter-connected constructs. This study proposes an AI-powered tool that integrates data-driven principles from both the HiTOP and symptom network models to generate individualized risk profiles for internalizing mental disorders (e.g., depression, anxiety, bipolar disorders). Our solution aims to assess individuals’ current psychopathological traits and symptom components, providing a comprehensive, nuanced profile supporting clinical diagnoses and monitoring.
The study unfolds in three phases: (1) model ideation; (2) model implementation in a large-scale Vietnamese sample; and (3) deployment in clinical and psychological practice settings in Vietnam. Central to our method is the development of a Risk-aware Taxonomy-enhanced Symptom Encoder (RiTaSE), which encodes symptom data and their severities into rich representations processed via a Transformer-based model. The model is trained using high-quality, validated datasets mapped to the HiTOP framework.
This project is among the first to employ AI for personalized psychopathological profiling in Vietnam,, as well as other low- and middle-income countries. Expected outcomes include an advanced diagnostic-support tool for clinical use, improved crosscultural insights into symptom comorbidity, and practical utility in mental health monitoring and intervention evaluation. Future extensions aim to broaden the scope across all HiTOP dimensions and predict transitions to clinical states through longitudinal and multi-modal data integration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has not received any funding yet.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study will use theoretical frameworks in psychopathology and exisiting evidence on its parameters and distribution to generate synthetic data to train and test AI model.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
hung.nguyen.khac.02{at}gmail.com
23C15032{at}student.hcmus.edu.vn
huyen.nth{at}vinuni.edu.vn
hieu.ph{at}vinuni.edu.vn
Data Availability
All data produced in the present study are available upon reasonable request to the authors
